Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-09-25
2009-06-23
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S242000, C544S333000, C548S303100, C548S302700, C514S386000
Reexamination Certificate
active
07550494
ABSTRACT:
Compounds of the formula Iwhich are useful for treating or preventing inflammatory and immune cell-mediated diseases. Exemplary are:
REFERENCES:
patent: 3668217 (1972-06-01), Fujinami et al.
patent: 3741981 (1973-06-01), Fujinami et al.
patent: 3846441 (1974-11-01), Mine et al.
patent: 4911748 (1990-03-01), Prisbylla
patent: 4944791 (1990-07-01), Schroder et al.
patent: 4977270 (1990-12-01), Wee
patent: 5208250 (1993-05-01), Cetenko et al.
patent: 5306822 (1994-04-01), Cetenko et al.
patent: 5334606 (1994-08-01), MacLeod
patent: 5464856 (1995-11-01), Cetenko et al.
patent: 5750553 (1998-05-01), Claussner et al.
patent: 6492408 (2002-12-01), Wu et al.
patent: 6689804 (2004-02-01), Wu et al.
patent: 6844360 (2005-01-01), Kelly et al.
patent: 6852748 (2005-02-01), Kelly et al.
patent: 2006/0229287 (2006-10-01), Brunette
patent: 2006/0264472 (2006-11-01), Barry et al.
patent: 19 40 032 (1970-03-01), None
patent: 19 58 183 (1970-06-01), None
patent: 21 00 800 1 (1971-07-01), None
patent: 0 091 596 (1983-10-01), None
patent: 0 343 643 (1989-11-01), None
patent: 0 545 478 (1993-06-01), None
patent: 51-88631 (1976-08-01), None
patent: 04273877 (1992-09-01), None
patent: WO 95 18794 (1995-07-01), None
patent: WO 98 39303 (1998-09-01), None
patent: WO 98 39303 (1998-09-01), None
patent: WO 99 11258 (1999-03-01), None
patent: WO 99 49856 (1999-10-01), None
Takayama, et al; “Quantitative Structure-activity Relationships of Antifungal 1-(3,5-Dichlorophenyl)-2,5-pyrrolidinediones and 3-(3,5-Diochlorophenyl)-2,4-oxazolidinediones”; Agric. Biol. Chem. 1982, 46, 2755-8.
LI, et al; “Examination of the Interrelationship Between Aliphatic Group Dipole moment and Polar Substituent Constants” J. Pharm. Sci. 1984; 73, 553-8.
Halim, et al; “3- 2-(3,5-Dimethylpyrazolyl)} Succinic Anhydride: Synthone for the Synthesis of Some Heterocycles with Potential Pharmaceutical Activity”; Monatshefte fuer Chemie, 1994, 125 1437-1442.
Database CA on STN, Chemical Abstracts, (Columbus, OH, USA) No. 128:204801, Hollinshead, S. et al, “Combinatorial process for preparing substituted pyrrolidine libraries”, Abstract WO 98 08813, Mar. 1998.
Database CA on STN, Chemical Abstracts, (Columbus, OH, USA) No. 124:145896, Drewes, M. et al, “Preparation of 4-(heterocyclo)-2-(sulfonamido) benzonitrile selective herbicides”, abstract DE4414568, Nov. 1995.
Musza, L. L., et al, “Potent New Cell Adhesion Inhibitory Compounds from the Root ofTrichilia rubra”; Tetrahedron, 1994, 50, 11369-11378.
Boschelli, D. H., et al; “3-Alkoxybenzo[b]thiophene-2-carboxamides as Inhibitors of Neutrophil-Endothelial Cell Adhesion”; J. Med. Chem, 1994., 37, 717.
Boschelli, D. H., et al; “Inhibition of E-Selectin-, ICAM-1-, and VCAM-1-Mediated Cell Adhesion by Benzo[b]thiophene-, Benzofuran-, Indole-, and Napthalene-2-carboxamides: Identification of PD 144795 as an Antiinflammatory Agent”; J. Med. Chem., 1995, 38, 4597-4614.
Sanfilippo, P. J., et al; “Novel Thiazole Based Heterocycles as Inhibitors of LFA-1/ICAM-1 Mediated Cell Adhesion”; J. Med. Chem. 1995, 38, 1057-1059.
Emeigh Jonathan Emillian
Goldberg Daniel R.
Kelly Terence Alfred
Lemieux Rene M.
Sorcek Ronald John
Boehringer Ingelheim Pharmaceuticals Inc.
Datlow Philip I.
Devlin Mary-Ellen M.
Morris Michael P.
Ward Paul V.
LandOfFree
Small molecules useful in the treatment of inflammatory disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Small molecules useful in the treatment of inflammatory disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small molecules useful in the treatment of inflammatory disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4143451